LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 93.96 | 27.76 | 154 | 6849 | 0.0225 | 0.2406 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 93.96 | 27.76 | 5440 | 6849 | 0.7943 | 0.9429 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 93.96 | 27.76 | 5 | 6849 | 0.0007 | -0.1940 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 93.96 | 27.76 | 646 | 6849 | 0.0943 | 0.4859 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 95.66 | 27.76 | 78 | 6712 | 0.0116 | 0.1394 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 95.66 | 27.76 | 5439 | 6712 | 0.8103 | 0.9476 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 95.66 | 27.76 | 6 | 6712 | 0.0009 | -0.1759 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 95.66 | 27.76 | 176 | 6712 | 0.0262 | 0.2627 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 1.95 | 27.76 | 615 | 225 | 2.7316 | 1.7896 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 1.95 | 27.76 | 9 | 225 | 0.0400 | -0.3113 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 1.95 | 27.76 | 587 | 225 | 2.6072 | 1.7469 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.66 | 27.76 | 690 | 283 | 2.4302 | 1.6061 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.66 | 27.76 | 14 | 283 | 0.0493 | -0.1846 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.66 | 27.76 | 571 | 283 | 2.0111 | 1.4631 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.36 | 27.76 | 756 | 320 | 2.3599 | 1.5510 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.36 | 27.76 | 13 | 320 | 0.0406 | -0.1934 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.36 | 27.76 | 651 | 320 | 2.0321 | 1.4451 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.06 | 27.76 | 825 | 360 | 2.2917 | 1.5029 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.06 | 27.76 | 21 | 360 | 0.0583 | -0.0727 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.06 | 27.76 | 734 | 360 | 2.0389 | 1.4250 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | I06 |